<DOC>
	<DOCNO>NCT00307619</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness tolerability topiramate compare placebo patient binge eat disorder receive Cognitive Behavior Therapy ( CBT )</brief_summary>
	<brief_title>An Efficacy Tolerability Study Topiramate Obese Patients With Binge Eating Disorder .</brief_title>
	<detailed_description>This 21-week multicenter , double-blind , parallel-group , randomize control trial compare efficacy tolerability add-on treatment 200mg topiramate versus placebo obese patient BED receive group CBT . The aim trial investigate efficacy tolerability adjunctive topiramate CBT obese patient BED improvement binge eating , related psychopathology , weight loss . The study hypothesis patient use topiramate + CBT loose weight patient use placebo + CBT.Tolerability investigate report adverse event dropout , reason leave study analyze . The randomized patient receive capsule topiramate ( 25 mg , 50 mg ) placebo correspondent daily 21 week</detailed_description>
	<mesh_term>Binge-Eating Disorder</mesh_term>
	<mesh_term>Feeding Eating Disorders</mesh_term>
	<mesh_term>Bulimia</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Have meeting diagnostic criterion binge eat disorder ( accord Diagnostic Statistical Manual Mental Disorders IV Edition criterion ) least 2 day binge eat per week severity least moderate defined binge eat scale ( score = 17 ) BMI = &gt; 30 kg/m2 &lt; 46 kg/m2 Women must post menopausal least one year surgically sterilize ( hysterectomy , tubal ligation ) , practice sexual abstinence use acceptable method birth control ( i.e . hormonal contraceptive , spermicide plus barrier method , intrauterine device and/or vasectomized partner ) Has history actual diagnostic significant psychiatric disorder ( schizophrenia , psychosis , major affective disorder , suicide risk , dementia , abuse alcohol drug ) malignancy history malignancy within past 5 year ( except basal cell carcinoma ) evidence uncontrolled thyroid disorder uncontrolled hypertension ( define diastolic blood pressure &gt; 110 mm/Hg and/or systolic blood pressure &gt; 180 mm/Hg without medication ) . Hypertensive patient medication must dose antihypertensive medication least two month history significant renal failure glaucoma .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Binge-Eating Disorder</keyword>
</DOC>